Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-24 5:50 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | Flynn James E | 3,283,824 5.71% | 3,283,824 (New Position) | View |
| 2024-02-14 9:01 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | Blue Owl Capital Holdings LP | 3,419,842 7.99% | 3,419,842 (New Position) | View |
| 2024-02-14 4:59 pm Sale | 13G | CULLINAN ONCOLOGY, INC. CGEM | Jovan-Embiricos Morana | 2,177,461 5.09% | -1,606,510 (-42.46%) | View |
| 2024-02-14 10:16 am Sale | 13G | CULLINAN ONCOLOGY, INC. CGEM | BIOTECHNOLOGY VALUE FUND L P | 4,393,321 9.99% | -3,115,738 (-41.49%) | View |
| 2024-02-13 5:02 pm Sale | 13G | CULLINAN ONCOLOGY, INC. CGEM | VANGUARD GROUP INC | 1,771,443 4.14% | -1,041,522 (-37.03%) | View |
| 2024-02-06 10:09 am Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | FRANKLIN RESOURCES INC BEN | 3,281,280 7.7% | 3,281,280 (New Position) | View |
| 2024-01-29 5:25 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BlackRock Inc. BLK | 2,462,274 5.8% | 425,623 (+20.90%) | View |
| 2023-09-07 09:38 am Sale | 13G | CULLINAN ONCOLOGY, INC. CGEM | BlackRock Inc. BLK | 2,036,651 4.8% | -469,564 (-18.74%) | View |
| 2023-02-15 11:42 am Sale | 13G | CULLINAN ONCOLOGY, INC. CGEM | Jovan-Embiricos Morana | 3,783,971 8.3% | -2,495,742 (-39.74%) | View |
| 2023-02-14 11:53 am Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BIOTECHNOLOGY VALUE FUND L P | 7,509,059 16.4% | 2,139,600 (+39.85%) | View |
| 2023-02-13 12:36 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | CHI Advisors LLC | 3,317,544 7.25% | 840,824 (+33.95%) | View |
| 2023-02-09 11:16 am Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | VANGUARD GROUP INC | 2,812,965 6.15% | 446,157 (+18.85%) | View |
| 2023-02-03 12:10 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BlackRock Inc. BLK | 2,506,215 5.5% | 2,506,215 (New Position) | View |
| 2022-02-14 1:23 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BIOTECHNOLOGY VALUE FUND L P | 5,369,459 12.3% | 975,000 (+22.19%) | View |
| 2022-02-11 3:05 pm Sale | 13G | CULLINAN ONCOLOGY, INC. CGEM | Foresite Capital Fund V L.P. | 1,524,008 3.5% | -2,117,871 (-58.15%) | View |
| 2022-02-11 1:39 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | CHI Advisors LLC | 2,476,720 5.67% | 2,476,720 (New Position) | View |
| 2022-02-10 4:49 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | Jovan-Embiricos Morana | 6,279,713 14.3% | 6,279,713 (New Position) | View |
| 2022-02-09 3:43 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | VANGUARD GROUP INC | 2,366,808 5.42% | 2,366,808 (New Position) | View |
| 2021-12-20 4:52 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BIOTECHNOLOGY VALUE FUND L P | 4,394,459 10.1% | 1,787,653 (+68.58%) | View |
| 2021-11-08 5:20 pm Purchase | 13G | CULLINAN ONCOLOGY, INC. CGEM | BIOTECHNOLOGY VALUE FUND L P | 2,606,806 6% | 2,606,806 (New Position) | View |